tirzepatide kidneys Cardiorenal benefits of tirzepatide. By reducing volume overload, Interplay of Chronic Kidney Disease

Monitor potassium levels in patients at risk for hypokalemia if indicated (e.g., patients using potassium-lowering medications, patients taking medications sensitive to serum potassium concentration)

At all dose sizes, tirzepatide met the trial's main goal of helping patients become free of the disease with no worsening of liver scarring compared with people who did not receive the treatment, according to the company's earnings presentation

L- , , ,

In contrast, lacosamide blocks the slow inactivation state, which may explain the added benefit of lacosamide in combination with carbamazepine

Sobos article on GLP-1 weight loss and muscle loss explains why the quality of weight loss matters as much as the quantity of weight lost